Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Altimmune, Inc. (ALT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
17.36+3.59 (+26.07%)
At close: 04:00PM EDT
17.25 -0.11 (-0.63%)
After hours: 07:41PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.77
Open13.80
Bid17.24 x 1200
Ask17.40 x 1400
Day's Range13.79 - 18.53
52 Week Range3.83 - 18.55
Volume8,829,626
Avg. Volume1,685,938
Market Cap689.862M
Beta (5Y Monthly)0.48
PE Ratio (TTM)N/A
EPS (TTM)-2.11
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 20, 2017
1y Target Est23.14
  • GlobeNewswire

    Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update

    Topline data from 12-week Phase 1b trial in subjects with obesity/overweight and non-alcoholic fatty liver disease (NAFLD) expected mid-September 2022GAITHERSBURG, Md., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three and six months ended June 30, 2022, and provided a business update. “We continue to advance the development of pemvidutide, our GLP-1/glucagon dual receptor agonist, and look

  • GlobeNewswire

    Altimmune to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11

    GAITHERSBURG, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2022 financial results on Thursday, August 11, 2022 and will provide a business update. Altimmune management will host a conference call at 8:30 am E.T. on August 11 to discuss financial results and provide a business update. The conference call will be webcast live on Altimmune’s Investor Relations website at https

  • Simply Wall St.

    Will Altimmune (NASDAQ:ALT) Spend Its Cash Wisely?

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Advertisement
Advertisement